Quantification of pre-existing radiographic damage and its relationship with joint activity and long-term clinical outcomes with secukinumab therapy in patients with psoriatic arthritis

BACKGROUND: Psoriatic arthritis (PsA) patient data from two phase 3 secukinumab trials (FUTURE 1, 5) were analysed to quantify the prevalence and extent of pre-existing radiographic damage (RD) at baseline; investigate the association of RD with swollen/tender joint counts (SJC/TJC) at baseline; and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip, van der Heijde, Désirée, Kirkham, Bruce, Schett, Georg, Orbai, Ana-Maria, Ritchlin, Christopher, Merola, Joseph F., Pricop, Luminita, James, David A., Zhu, Xuan, Ligozio, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795644/
https://www.ncbi.nlm.nih.gov/pubmed/36578042
http://dx.doi.org/10.1186/s13075-022-02944-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795644/
https://www.ncbi.nlm.nih.gov/pubmed/36578042
http://dx.doi.org/10.1186/s13075-022-02944-1

Ejemplares similares